Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines.

Autor: Sergeeva MV; Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia., Romanovskaya-Romanko EA; Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia., Krivitskaya VZ; Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia., Kudar PA; 'Institute of Experimental Medicine', 197022 Saint Petersburg, Russia., Petkova NN; 'Institute of Experimental Medicine', 197022 Saint Petersburg, Russia., Kudria KS; Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia., Lioznov DA; Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia., Stukova MA; Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197022 Saint Petersburg, Russia., Desheva YA; 'Institute of Experimental Medicine', 197022 Saint Petersburg, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2023 Nov 20; Vol. 11 (11). Date of Electronic Publication: 2023 Nov 20.

SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.

Autor: Vakhrusheva AV; Betuvax LLC, 121096 Moscow, Russia.; Department of Bioengineering, Biological Faculty, Lomonosov Moscow State University, 119991 Moscow, Russia., Kudriavtsev AV; Betuvax LLC, 121096 Moscow, Russia.; Department of Bioengineering, Biological Faculty, Lomonosov Moscow State University, 119991 Moscow, Russia., Kryuchkov NA; Clinical Excellence Group LLC, 127051 Moscow, Russia., Deev RV; Department of Pathological Anatomy, I.I. Mechnikov North-Western State Medical University, 195067 Saint Petersburg, Russia., Frolova ME; PJSC Human Stem Cells Institute, 129110 Moscow, Russia., Blagodatskikh KA; Center of Genetics and Reproductive Medicine 'Genetico', 119333 Moscow, Russia., Djonovic M; Betuvax LLC, 121096 Moscow, Russia., Nedorubov AA; Center for Preclinical Studies, Sechenov First Moscow State Medical University, 119435 Moscow, Russia., Odintsova E; Center for Preclinical Studies, Sechenov First Moscow State Medical University, 119435 Moscow, Russia., Ivanov AV; Biotechnology Developments LLC, 119285 Moscow, Russia., Romanovskaya-Romanko EA; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Stukova MA; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Isaev AA; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.; Center of Genetics and Reproductive Medicine 'Genetico', 119333 Moscow, Russia., Krasilnikov IV; Biotechnology Developments LLC, 119285 Moscow, Russia.; Department of Vaccinology, Smorodintsev Research Institute of Influenza, Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Aug 10; Vol. 10 (8). Date of Electronic Publication: 2022 Aug 10.

Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2.

Autor: Krasilnikov IV; Department of Vaccinology, Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Kudriavtsev AV; Betuvax, 121096 Moscow, Russia., Vakhrusheva AV; Betuvax, 121096 Moscow, Russia., Frolova ME; PJSC Human Stem Cells Institute, 129110 Moscow, Russia., Ivanov AV; Razvitie BioTechnologiy, 119136 Moscow, Russia., Stukova MA; Department of Vaccinology, Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Romanovskaya-Romanko EA; Department of Vaccinology, Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Vasilyev KA; Department of Vaccinology, Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation, 197376 Saint Petersburg, Russia., Mushenkova NV; Betuvax, 121096 Moscow, Russia., Isaev AA; PJSC Human Stem Cells Institute, 129110 Moscow, Russia.; Center of Genetics and Reproductive Medicine 'Genetico', 119333 Moscow, Russia.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Jan 02; Vol. 10 (1). Date of Electronic Publication: 2022 Jan 02.

Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.

Autor: Karyagina AS; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. akaryagina@gmail.com.; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia., Gromov AV; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Grunina TM; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia., Lyaschuk AM; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Grishin AV; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Strukova NV; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Generalova MS; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Galushkina ZM; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Soboleva LA; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Dobrinina OY; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Bolshakova TN; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Subbotina ME; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. subbotinam@gmail.com.; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia., Romanovskaya-Romanko EA; Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, 197376, Russia., Krasilnikov IV; Saint Petersburg Institute of Vaccines and Sera, FMBA, St. Petersburg, 198320, Russia., Polyakov NB; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.; Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia., Solovyev AI; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Grumov DA; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Zhukhovitsky VG; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Ryabova EI; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Prokofiev VV; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia., Lunin VG; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.

Publikováno v: Biochemistry. Biokhimiia [Biochemistry (Mosc)] 2021 Oct; Vol. 86 (10), pp. 1275-1287.

[Impact of mutations in nucleoprotein on replication of influenza virus A/Hong Kong/1/68/162/35 reassortants at different temperatures].

Autor: Pulkina AA; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia.; Peter the Great St. Petersburg Polytechnic University, Saint-Petersburg, 195251 Russia., Sergeeva MV; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia.; mari.v.sergeeva@gmail.com., Petrov SV; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia., Fadeev AV; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia., Komissarov AB; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia., Romanovskaya-Romanko EA; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia., Potapchuk MV; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia., Tsybalova LM; Research Institute of Influenza WHO National Influenza Centre of Russia, St. Petersburg, 197376 Russia.

Publikováno v: Molekuliarnaia biologiia [Mol Biol (Mosk)] 2017 Mar-Apr; Vol. 51 (2), pp. 378-383.